SYDNEY – The iQ Group Global has announced its equity crowd-sourced funding platform Capital Labs has launched a new investment offer, driving a new era in Australian Healthcare.
One of the first ASIC authorised equity crowd-sourced funding (CSF) platforms in Australia, Capital Labs only partners with companies launching technology and innovations that have a positive impact on Australia’s future. For investors, Capital Labs provides access to early-stage retail investment opportunities in innovative companies and technologies in a variety of sectors for as little as $100.
Capital Labs is excited to announce its partnership with Greenfield MC Global, a medicinal cannabis enterprise focused on the development and distribution of pharmaceutical-grade medicinal cannabis products for the Asia Pacific region.
“At Greenfield MC Global, we strive to help shape this new era in patient care,” said Arjun Chhabra, Chairman and President, Greenfield MC Global.
“We are delighted to partner with Capital Labs to invite retail investors, who believe it’s time for change in Australia and the Asia Pacific, to participate in this raise,” he said.
Part of bioscience investment enterprise The iQ Group Global, Capital Labs backs innovative companies with a unique full-service crowdfunding raise offering, including investment banking, marketing and advisory services.
Dr. George Syrmalis, Chief Executive Officer of The iQ Group Global, said the offer aligns with the core mission of Capital Labs.
“Capital Labs is a platform for Australians who believe in investing in positive change,” Dr Syrmalis said.
“Providing retail investors the opportunity to
fund companies bringing meaningful innovations to market in sectors alongside
life science, Capital Labs exemplifies our commitment to innovation,” he
The Greenfield MC Global offer is live now, closing on December 12 2019.
To invest, visit https://capitallabs.com/greenfieldmc
For more information about Greenfield MC Global and their Capital Labs CSF, watch the offer video here:
About Capital Labs
Capital Labs is an equity crowd-funding platform dedicated to launching innovations with impact.
About The iQ Group Global
The iQ Group Global is a group of companies that find, fund and develop bioscience discoveries to create life-changing medical innovations. The Group’s flagship innovation is the Saliva Glucose Biosensor, the first non-invasive replacement for finger-prick blood glucose testing for people living with diabetes. Visit our website: www.theiqgroupglobal.com.
About Greenfield MC Global
Greenfield MC Global is a licensed medicinal cannabis importer and distributor in Australia, with expanding operations in cultivation, research and distribution in New Zealand, South Korea, the Philippines and other Asia-Pacific markets.